Search results for "Macular degeneration"

showing 10 items of 114 documents

Changes in neurophysiologic markers of visual processing following beneficial anti-VEGF treatment in macular degeneration

2013

Pasi Vottonen,1 Kai Kaarniranta,1,2 Ari Pääkkönen,3 Ina M Tarkka41Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland; 2Department of Ophthalmology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; 3Department of Clinical Neurophysiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; 4Department of Health Sciences, University of Jyväskylä, Jyväskylä, FinlandPurpose: Antivascular endothelial growth factor (VEGF) agents have been shown to improve visual acuity and prevent vision loss in exudative age-related macular degeneration. As the vision im…

medicine.medical_specialtyVisual acuityexudative age-related macular degenerationvisual acuitygenetic structuresvisual evoked potentialsVEGF receptorsta3112Cortical processingVisual processingText miningOphthalmologymedicinescalp-recorded EEGage-related eye diseasesOriginal Researchbiologybusiness.industryta3141Clinical OphthalmologyMacular degenerationmedicine.diseaseeye diseasesOphthalmologybiology.proteinElectrophysiological markerssense organsAnti vegf treatmentmedicine.symptombusinessClinical Ophthalmology
researchProduct

Is Homelessness a Risk Factor for Eye Disease?

2005

<i>Background:</i> There is general agreement on the presence of a correlation between poverty and impaired health. However, only scarce data are available on whether this also applies to the incidence of eye disease. The present study was carried out to evaluate the prevalence of ocular disease in homeless people in Germany. <i>Methods:</i> 107 homeless people (97 male, 10 female; mean age 49 years, range 18–81 years) treated in specialised social service institutions were investigated prospectively according to a standardised ophthalmological screening protocol. This comprised visual acuity, assessment of pupillary light reaction, intra-ocular pressure, slit lamp e…

medicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryEye diseaseGeneral MedicineDiabetic retinopathyMacular degenerationmedicine.diseaseeye diseasesSensory SystemsVision disorderOphthalmologyOphthalmologyEpidemiologymedicineCranial nerve diseasesense organsmedicine.symptomRisk factorbusinessOphthalmologica
researchProduct

RheoNet Registry Analysis of Rheopheresis for Microcirculatory Disorders With a Focus on Age-Related Macular Degeneration

2010

The purpose of establishing the RheoNet registry was to evaluate the safety and efficacy of rheopheresis, a specific method of therapeutic apheresis used to treat microcirculatory disorders. Apheresis centers providing rheopheresis therapy and physicians caring for the underlying disease were asked to participate in the registry, and the registry data were analyzed for safety and tolerability. Age-related macular degeneration (AMD) was selected as a model disease to evaluate efficacy. The RheoNet registry was successfully established recording 7722 rheopheresis treatments of 1110 patients, including 833 AMD patients. The mean age of patients was 72 years. Adverse events (AE) were reported i…

medicine.medical_specialtyVisual acuitygenetic structuresbusiness.industryRheopheresisHematologyMacular degenerationmedicine.diseaseeye diseasesSurgeryApheresisTolerabilityNephrologyAge relatedInternal medicinemedicinemedicine.symptomAdverse effectbusinessTherapeutic apheresisTherapeutic Apheresis and Dialysis
researchProduct

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degenera…

2011

Roberto Gallego-Pinazo,1,2 Ana Marina Suelves-Cogollos1, Ester Francés-Muñoz,1 J María Millán,2,3 J Fernando Arevalo,4 J Luis Mullor,5 Manuel Díaz-Llopis,1,2,61Department of Ophthalmology, Hospital Universitario La Fe, Valencia, Spain; 2Centro de Investigación Biomédica en Red de Enfermedades Raras, Valencia, Spain; 3Department of Genetics, Hospital Universitario La Fe, Valencia, Spain; 4Retina and Vitreous Service, Clínica Oftalmológica Centro Caracas, Caracas, Venezuela; 5Unit of Experimental Ophthalmology, Fundación para la Investigación del Hospital Universitario La F…

medicine.medical_specialtyVisual acuitygenetic structureschoroidal neovascularizationOptical coherence tomographyOphthalmologymedicineMetamorphopsiadrusenoid pigment epithelial detachmentranibizumabage-related macular degenerationOriginal Researchsoft drusenmedicine.diagnostic_testbusiness.industryClinical OphthalmologyDiabetic retinopathyMacular degenerationmedicine.diseaseeye diseasesOphthalmologyChoroidal neovascularizationsense organsRanibizumabmedicine.symptomIntravitreal ranibizumabbusinessmedicine.drugClinical Ophthalmology
researchProduct

Photodynamic Therapy in Subfoveal Choroidal Neovascularisation

2002

Summary The exudative form of age-related macular degeneration (AMD) is the leading cause of blindness among people over 50 years of age in the western world. In 2–10% of cases a subfoveal choroidal neovascularisation develops. Conventional laser treatment leads to an unspecific destruction of the CNV including adjacent retinal structures. In addition, significant and immediate vision loss occurs, particularly in cases with central, subfoveal localization of the CNV.Photodynamic therapy (PDT) employing photochemical activation of verteporfin as a photosensitizer induces selective occlusion of CNV with minimal damage to the neurosensory retina and does not impair visual acuity. It became ava…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentPhotodynamic therapyDermatologychemistry.chemical_compoundOphthalmologyOcclusionmedicineRetinabusiness.industryLaser treatmentRetinalMacular degenerationmedicine.diseaseVerteporfineye diseasesSurgerymedicine.anatomical_structurechemistrySurgerysense organsmedicine.symptombusinessmedicine.drugMedical Laser Application
researchProduct

Urgent Vitrectomy with Vancomycin Infusion, Silicone Oil Endotamponade, and General Antibiotic Treatment in Multiple Cases of Endophthalmitis from a …

2021

The aim of this study was to report on the anatomical and functional results of surgical management of seven cases of endophthalmitis related to a single day of intravitreal aflibercept injections. Patients with signs of endophthalmitis who underwent aflibercept injections (seven eyes) performed on the same day were retrospectively evaluated. The data of visual acuity and optical coherence tomography (OCT) within nine months of the follow-up and the treatment and results of microbiological cultures are reported. Four of the total seven cases had a positive bacterial culture outcome (Streptococcus mitis). All patients underwent vitrectomy combined with phacoemulsification when the eyes were …

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.medical_treatmentlcsh:MedicineVitrectomyBacterial endophthalmitiArticle03 medical and health sciences0302 clinical medicineEndophthalmitisOphthalmologymedicinepost-injection endophthalmitis030212 general & internal medicineAfliberceptendophthalmitis treatmentbusiness.industrylcsh:Rbacterial endophthalmitisGeneral MedicinePhacoemulsificationMacular degenerationmedicine.disease<i>Streptococcus mitis/oralis</i>eye diseasesStreptococcus mitis/oralis030221 ophthalmology & optometryVancomycinTamponadeBacterial endophthalmitis; En-dophthalmitis treatment; Post-injection endophthalmitis; Streptococcus mitis/oralissense organsmedicine.symptomPost-injection endophthalmitiEn-dophthalmitis treatmentbusinessmedicine.drugJournal of Clinical Medicine
researchProduct

The LDL receptor in the retina: the missing link in aging, the new target in dietary prevention

2012

National audience; Purpose: The discovery of the LDL receptor (LDLR) in 1985 by Brown and Goldstein was awarded by a Nobel Prize. The LDLR has initially been identified for its role in mediating the endocytosis of LDL particles in the vascular endothelium. The deposition of lipids, including cholesterol and cholesteryl esters in Bruch’s Membrane in the one hand, and in the vessel intima in the other hand, is one of the common features of age related macular degeneration (AMD) and cardiovascular disease (CVD). Dietary habits with high intakes of omega 3 long chain fatty acids (LCFA) have been associated with AMD prevention. Similar effects have been demonstrated in CVD prevention. The mechan…

medicine.medical_specialtygenetic structures030309 nutrition & dieteticsLinoleic acidEndocytosis03 medical and health scienceschemistry.chemical_compound0404 agricultural biotechnologyInternal medicineGene expressionmedicinecardiovascular diseases[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs0303 health sciencesRetinaCholesterolbusiness.industry04 agricultural and veterinary sciencesGeneral MedicineMacular degenerationmedicine.disease040401 food scienceeye diseases3. Good healthOphthalmologyEndocrinologymedicine.anatomical_structurechemistryHumanized mouseLDL receptorlipids (amino acids peptides and proteins)sense organsbusiness[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Evolving European guidance on the medical management of neovascular age related macular degeneration

2006

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in development, and data from phase III clinical trials of some of these pharmacological interventions are now available. In light of these new data, expert guidance is required to enable retina specialists with expertise in the management of AMD to select and use the most appropriate therapies for the treatment of neovascular AMD. METHODS: Consensus from a round table of European retina specialists was obt…

medicine.medical_specialtygenetic structuresBevacizumabAntibodies Monoclonal HumanizedTriamcinolone AcetonideMacular DegenerationCellular and Molecular NeuroscienceRanibizumabOphthalmologymedicineHumansPregnadienediolsEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryAntibodies MonoclonalAptamers NucleotideMacular degenerationFluorescein angiographymedicine.diseaseVerteporfinChoroidal Neovascularizationeye diseasesSensory SystemsOphthalmologyTreatment Outcomemedicine.anatomical_structureChoroidal neovascularizationPhotochemotherapyPerspectivesense organsAnecortave acetateChoroidRanibizumabmedicine.symptombusinessmedicine.drugBritish Journal of Ophthalmology
researchProduct

Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies

2022

Globally, 2.2 billion people live with some form of vision impairment and/or eye disease. To date, most systematic reviews examining associations have focused on a single eye disease and there is no systematic evaluation of the relationships between eye diseases and diverse physical and mental health outcomes. Moreover, the strength and reliability of the literature is unclear. We performed an umbrella review of observational studies with meta analyses for any physical and/or mental comorbidities associated with eye disease. For each association, random-effects summary effect size, heterogeneity, small-study effect, excess significance bias and 95% prediction intervals were calculated, and …

medicine.medical_specialtygenetic structuresEye diseaseDiseaseType 2 diabetesReview ArticleCataractCognitionEye diseasePregnancyRisk FactorsDiabetes mellitusInternal medicinemedicineHumansDepression (differential diagnoses)Diabetic Retinopathybusiness.industryInfant NewbornReproducibility of ResultsRetinopathy of prematurityGlaucomaDiabetic retinopathyMacular degenerationmedicine.diseaseeye diseasesOphthalmologyObservational Studies as TopicDiabetes Mellitus Type 2Femalebusiness
researchProduct

Current Clinical Application of Microperimetry: A Review.

2018

Microperimetry (MP) is a technology that allows the study of retinal sensitivity at different foveal and parafoveal areas as well as eye fixation. It is a technique of functional evaluation, providing a direct correlation between anatomical and functional outcomes. There are a great variety of studies which evaluate the repeatability or reliability of measurements obtained with this technology and also describe and explore different clinical applications. MP has been shown to be useful in the characterization of sensory and motor conditions, such as amblyopia or nystagmus. Concerning ocular pathology, several studies have confirmed the usefulness of MP for evaluating and analyzing different…

medicine.medical_specialtygenetic structuresOcular PathologyGlaucomaNystagmusFixation OcularAmblyopiaMicroperimetryOcular Motility Disorders03 medical and health scienceschemistry.chemical_compoundNystagmus0302 clinical medicineOcular Motility DisordersRetinal DiseasesFovealOphthalmologymedicineHumansRetinal sensitivityVisual rehabilitationÓpticabusiness.industryReproducibility of ResultsRetinalGeneral MedicineMacular degenerationmedicine.diseaseeye diseasesOphthalmologychemistryEye fixation030221 ophthalmology & optometryVisual Field Testsmedicine.symptomVisual FieldsbusinessMicroperimetry030217 neurology & neurosurgerySeminars in ophthalmology
researchProduct